MedPath

Effect of Berberis root active component (Berberine) in patients with Type2 Diabetes.

Phase 3
Conditions
Type 2 Diabet.
Non-insulin-dependent diabetes mellitus
Registration Number
IRCT2013040712933N1
Lead Sponsor
Vice chancellor for research Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
84
Inclusion Criteria

Age 30-65 years; HbA1C 7-8.5; Fasting Blood Sugar 126 -200; diagnosis of Diabetes less than 10 years; Only use oral blood glucose lowering drugs .
Exclusion critria: Fasting Blood Sugar More Than 200; HbA1C More Than 8.5 ;triglyceride More Than 500; pregnancy; Consumers of anticoagulants drugs
(except Aspirin); chronic liver disease except fatty liver disease; proliferative Diabetic retinopathy; Renal Failure; Heart failure; Hemorrhagic strokes; hypothyroidism and hyperthyroidism; treatment with Insulin.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasting Blood Sugar. Timepoint: baseline , after four weeks. Method of measurement: Blood samples from patients, mg/dl.;2hpp( 2 hour post prandial). Timepoint: baseline , after four weeks. Method of measurement: Blood samples from patients, mg/dl.;Fructosamine. Timepoint: baseline , after four weeks. Method of measurement: Blood samples from patients ,umol.
Secondary Outcome Measures
NameTimeMethod
ipid profile. Timepoint: baseline , after four weeks. Method of measurement: Blood samples from patients,Mg per deciliter.;Blood pressure. Timepoint: baseline , after four weeks. Method of measurement: Manometer, mmHg.;Body Mass Index. Timepoint: baseline , after four weeks. Method of measurement: Scale,Meter,Kg/m2.
© Copyright 2025. All Rights Reserved by MedPath